Last updated: July 29, 2024
Sponsor: Aydin Adnan Menderes University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Circulation Disorders
Dizzy/fainting Spells
Vascular Diseases
Treatment
HYPOTENSİON
Clinical Study ID
NCT06414811
2024-44
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Written informed consent;
18-75 years old
ASA Physical Status 1-3;
Patients planned for surgery
Exclusion
Exclusion Criteria:
The patient is pregnant
After cardiac surgery
Severe pulmonary hypertension
Severe valve disease
Hypertrophic or dilated cardiomyopathy
Presence of acute myocardial infarction
Patients with severe visual or hearing impairment/disability
ASA physical status IV or V
Ischemic heart disease, conduction disorder.
Study Design
Total Participants: 52
Treatment Group(s): 1
Primary Treatment: HYPOTENSİON
Phase:
Study Start date:
May 15, 2024
Estimated Completion Date:
March 15, 2025
Study Description
Connect with a study center
Ferdi Gülaştı
Aydın, 09020
TurkeyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.